Literature DB >> 24982317

Viruses and human cancers: a long road of discovery of molecular paradigms.

Martyn K White1, Joseph S Pagano2, Kamel Khalili3.   

Abstract

About a fifth of all human cancers worldwide are caused by infectious agents. In 12% of cancers, seven different viruses have been causally linked to human oncogenesis: Epstein-Barr virus, hepatitis B virus, human papillomavirus, human T-cell lymphotropic virus, hepatitis C virus, Kaposi's sarcoma herpesvirus, and Merkel cell polyomavirus. Here, we review the many molecular mechanisms of oncogenesis that have been discovered over the decades of study of these viruses. We discuss how viruses can act at different stages in the complex multistep process of carcinogenesis. Early events include their involvement in mutagenic events associated with tumor initiation such as viral integration and insertional mutagenesis as well as viral promotion of DNA damage. Also involved in tumor progression is the dysregulation of cellular processes by viral proteins, and we describe how this has been investigated by studies in cell culture and in experimental animals and by molecular cellular approaches. Also important are the molecular mechanisms whereby viruses interact with the immune system and the immune evasion strategies that have evolved.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24982317      PMCID: PMC4135891          DOI: 10.1128/CMR.00124-13

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  188 in total

1.  Hepatocyte transformation and tumor development induced by hepatitis C virus NS3 c-terminal deleted protein.

Authors:  Qiong-Qiong He; Rui-Xue Cheng; Yi Sun; De-Yun Feng; Zhu-Chu Chen; Hui Zheng
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

2.  Replication of EBV in epithelial cells during infectious mononucleosis.

Authors:  S M Lemon; L M Hutt; J E Shaw; J L Li; J S Pagano
Journal:  Nature       Date:  1977-07-21       Impact factor: 49.962

3.  Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.

Authors:  S D Abbot; M Rowe; K Cadwallader; A Ricksten; J Gordon; F Wang; L Rymo; A B Rickinson
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

4.  The human papillomavirus type 8 E6 protein interferes with NOTCH activation during keratinocyte differentiation.

Authors:  Jordan M Meyers; Jennifer M Spangle; Karl Munger
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

5.  Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens.

Authors:  Roland Houben; Masahiro Shuda; Rita Weinkam; David Schrama; Huichen Feng; Yuan Chang; Patrick S Moore; Jürgen C Becker
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

6.  DNA of a human hepatitis B virus candidate.

Authors:  W S Robinson; D A Clayton; R L Greenman
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

7.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

8.  Antigenic mimicry of an immunoglobulin A epitope by a hepatitis B virus cell attachment site.

Authors:  A R Neurath; N Strick
Journal:  Virology       Date:  1990-10       Impact factor: 3.616

Review 9.  Notch and Wnt signaling: mimicry and manipulation by gamma herpesviruses.

Authors:  S Diane Hayward; Jianyong Liu; Masahiro Fujimuro
Journal:  Sci STKE       Date:  2006-05-16

10.  The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation.

Authors:  Jianmin Zuo; Andrew Currin; Bryan D Griffin; Claire Shannon-Lowe; Wendy A Thomas; Maaike E Ressing; Emmanuel J H J Wiertz; Martin Rowe
Journal:  PLoS Pathog       Date:  2009-01-02       Impact factor: 6.823

View more
  50 in total

1.  Contribution of Beta-HPV Infection and UV Damage to Rapid-Onset Cutaneous Squamous Cell Carcinoma during BRAF-Inhibition Therapy.

Authors:  Daniel N Cohen; Steven K Lawson; Aaron C Shaver; Liping Du; Harrison P Nguyen; Qin He; Douglas B Johnson; Wilfred A Lumbang; Brent R Moody; James L Prescott; Pranil K Chandra; Alan S Boyd; Jeffrey P Zwerner; Jason B Robbins; Stephen K Tyring; Peter L Rady; James D Chappell; Yu Shyr; Jeffrey R Infante; Jeffrey A Sosman
Journal:  Clin Cancer Res       Date:  2015-02-27       Impact factor: 12.531

Review 2.  αβ TCR-mediated recognition: relevance to tumor-antigen discovery and cancer immunotherapy.

Authors:  Ellis L Reinherz
Journal:  Cancer Immunol Res       Date:  2015-04       Impact factor: 11.151

Review 3.  Advances in targeting 'undruggable' transcription factors with small molecules.

Authors:  Matthew J Henley; Angela N Koehler
Journal:  Nat Rev Drug Discov       Date:  2021-05-18       Impact factor: 84.694

Review 4.  The CRISPR/Cas9 genome editing methodology as a weapon against human viruses.

Authors:  Martyn K White; Wenhui Hu; Kamel Khalili
Journal:  Discov Med       Date:  2015-04       Impact factor: 2.970

Review 5.  Approved Antiviral Drugs over the Past 50 Years.

Authors:  Erik De Clercq; Guangdi Li
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

6.  Immediate Antiretroviral Therapy Reduces Risk of Infection-Related Cancer During Early HIV Infection.

Authors:  Álvaro H Borges; Jacqueline Neuhaus; Abdel G Babiker; Keith Henry; Mamta K Jain; Adrian Palfreeman; Peter Mugyenyi; Pere Domingo; Christian Hoffmann; Tim R H Read; Sanjay Pujari; Michael Meulbroek; Margaret Johnson; Timothy Wilkin; Ronald Mitsuyasu
Journal:  Clin Infect Dis       Date:  2016-09-08       Impact factor: 9.079

Review 7.  Application of viromics: a new approach to the understanding of viral infections in humans.

Authors:  Mageshbabu Ramamurthy; Sathish Sankar; Rajesh Kannangai; Balaji Nandagopal; Gopalan Sridharan
Journal:  Virusdisease       Date:  2017-12-05

8.  Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents.

Authors:  Andreas Kyvernitakis; Parag Mahale; Uday R Popat; Ying Jiang; Jeff Hosry; Richard E Champlin; Harrys A Torres
Journal:  Biol Blood Marrow Transplant       Date:  2015-12-19       Impact factor: 5.742

9.  Opportunities During Early Life for Cancer Prevention: Highlights From a Series of Virtual Meetings With Experts.

Authors:  Dawn M Holman; Natasha D Buchanan
Journal:  Pediatrics       Date:  2016-11       Impact factor: 7.124

10.  Antiviral therapy improves overall survival in hepatitis C virus-infected patients who develop diffuse large B-cell lymphoma.

Authors:  Jeff Hosry; Parag Mahale; Francesco Turturro; Roberto N Miranda; Minas P Economides; Bruno P Granwehr; Harrys A Torres
Journal:  Int J Cancer       Date:  2016-08-18       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.